Cahill Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$336K Hold
955
0.04% 227
2025
Q4
$313K Sell
955
-103
-10% -$32.7K 0.03% 238
2025
Q3
$299K Buy
+1,058
New +$307K 0.03% 240
2025
Q2
Sell
-657
Closed -$205K 274
2025
Q1
$205K Buy
+657
New +$194K 0.03% 259
2024
Q1
Sell
-1,045
Closed -$301K 260
2023
Q4
$301K Buy
+1,045
New +$285K 0.04% 198

Other funds holding AMGN

Cahill Financial Advisors's AMGN Position: Q1 2026 in Review

Cahill Financial Advisors held its Amgen (AMGN) position steady in Q1 2026 at 955 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #227.

Cahill Financial Advisors first reported a position in AMGN in Q4 2023 and has held it in 5 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cahill Financial Advisors held 955 shares of Amgen worth $336K as of Q1 2026.
  • Cahill Financial Advisors left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.04% of Cahill Financial Advisors's portfolio in Q1 2026, its #227 holding.
  • Cahill Financial Advisors first reported a position in Amgen in Q4 2023 and has held it in 5 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cahill Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.